0001846253-24-000011.txt : 20240423 0001846253-24-000011.hdr.sgml : 20240423 20240423174009 ACCESSION NUMBER: 0001846253-24-000011 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221101 FILED AS OF DATE: 20240423 DATE AS OF CHANGE: 20240423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cochran Jennifer R. CENTRAL INDEX KEY: 0001872349 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40720 FILM NUMBER: 24866113 MAIL ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC STREET 2: 3911 SORRENTO VALLEY BOULEVARD, STE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OmniAb, Inc. CENTRAL INDEX KEY: 0001846253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-250-7800 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 600 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Avista Public Acquisition Corp. II DATE OF NAME CHANGE: 20210212 4/A 1 wk-form4a_1713908398.xml FORM 4/A X0508 4/A 2022-11-01 2022-11-03 0 0001846253 OmniAb, Inc. OABI 0001872349 Cochran Jennifer R. 5980 HORTON STREET, STE 600 EMERYVILLE CA 94608 1 0 0 0 0 Common Stock 2022-11-01 4 A 0 25518 A 93378 D Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. This amendment is being filed to correct a Form 4 filed on November 3, 2022, which inadvertently understated the number of shares beneficially held by the Reporting Person following the transaction reported by 292 shares. The number reported in column 4 represents the correct number of shares acquired by the Reporting Person as of November 1, 2022, which included (1) 12,545 restricted stock units and (2) 11,076 earn-out shares. Represents the number of shares beneficially held by the Reporting Person as of the date of this filing, as adjusted for the administrative error identified in footnote 2. By: /s/ Charles S. Berkman, Attorney-in-Fact For: Jennifer R. Cochran 2024-04-23